Šeila Selimović is Director of three NIBIB programs: Tissue Chips, Biosensors, and Microfluidic Bioanalytical Systems. Her programmatic activities also include a focus on tissue preservation technologies (e.g. cryopreservation, organ preservation for transplants) and technologies like bioprinting. Her other scientific interests include wearable sensors, paper diagnostic devices, and smart materials. In 2015, she was selected as one of the "50 Leaders of Tomorrow" from among hundreds of young biotech leaders in the Mid-Atlantic region. Prior to her current position, she was chosen by the American Association for the Advancement of Science to serve as a Science and Technology Policy Fellow to serve at the U.S. Department of State, where she covered science diplomacy issues related to energy security, climate, and innovation. Before that, she was a Postdoctoral Research Fellow at Harvard Medical School and Brigham & Women’s Hospital in Boston, Massachusetts. Dr. Selimović’s research has focused on the development of microfluidic platforms for applications in biophysics and biological engineering, including the physics of microscale flows, protein crystallization, colloidal suspensions, as well as rheology and microrheology. Dr. Selimović earned her Ph.D. and M. Sc. degrees in Physics from Brandeis University, with National Science Foundation support, and her B.A. degree in Physics and German from Wellesley College. She is a member of Sigma Xi.